MEDGENICS, INC. 4
4 · MEDGENICS, INC. · Filed Feb 14, 2014
Insider Transaction Report
Form 4
MEDGENICS, INC.MDGN
Pearlman Andrew
President and CEO
Transactions
- Exercise/Conversion
Common Stock
2014-02-12$3.14/sh+11,168$35,068→ 51,730 total - Sale
Common Stock
2014-02-12$9.00/sh−11,168$100,512→ 40,562 total - Exercise/Conversion
Option Award (right to buy)
2014-02-12−11,168→ 34,632 totalExercise: $3.14Exp: 2014-09-13→ Common Stock (11,168 underlying)
Holdings
- 94(indirect: By Spouse)
Common Stock
- 1,719(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2013.
- [F2]The option award became fully exercisable on September 13, 2013 in accordance with the terms of the reporting person's separation agreement entered into upon his resignation as the issuer's President and Chief Executive Officer.